Deficiency of a transcriptional regulator, inhibitor of differentiation 3, induces glomerulonephritis in apolipoprotein E-deficient mice: A model linking hyperlipidemia and renal disease

American Journal of Pathology

Volumn 179, Issue 2, 2011, Pages 651-660

  Bagavant, Harini ^a   Scindia, Yogesh ^a   Nackiewicz, Dominika ^a   Rao Nandula, Seshagiri ^a   Doran, Amanda ^a   Cutchins, Alexis ^a   Oldham, Stephanie ^a   Deshmukh, Umesh ^a   McNamara, Coleen ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; APOLIPOPROTEIN E; AUTOANTIBODY; CD68 ANTIGEN; CELL ANTIGEN; CREATININE; FIBRONECTIN; IMMUNOGLOBULIN G; KI 67 ANTIGEN; LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN ANTIBODY COMPLEX; ARTICLE; AUTOIMMUNITY; CELL INFILTRATION; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE URINE LEVEL; DISEASE ASSOCIATION; ELECTRON MICROSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULOSCLEROSIS; HYPERLIPIDEMIA; HYPERLIPOPROTEINEMIA TYPE 3; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; MACROPHAGE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MICROALBUMINURIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; WESTERN BLOTTING;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; APOLIPOPROTEINS E; ATHEROSCLEROSIS; FEMALE; GENE EXPRESSION REGULATION; GLOMERULONEPHRITIS; IMMUNE SYSTEM; IMMUNOGLOBULIN G; INHIBITOR OF DIFFERENTIATION PROTEINS; KIDNEY; KIDNEY DISEASES; LIPIDS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MICROSCOPY, ELECTRON; RISK FACTORS;

EID: 80052507064     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.04.029     Document Type: Article

References (33)

1. O. Samuelsson, H. Mulec, C. Knight-Gibson, P.O. Attman, B. Kron, R. Larsson, L. Weiss, H. Wedel, and P. Alaupovic Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency Nephrol Dial Transplant 12 1997 1908 1915 (Pubitemid 27379464)
2. D. Kees-Folts, and J.R. Diamond Relationship between hyperlipidemia, lipid mediators, and progressive glomerulosclerosis in the nephrotic syndrome Am J Nephrol 13 1993 365 375 (Pubitemid 24014484)
3. E.S. Schaeffner, T. Kurth, G.C. Curhan, R.J. Glynn, K.M. Rexrode, C. Baigent, J.E. Buring, and J.M. Gaziano Cholesterol and the risk of renal dysfunction in apparently healthy men J Am Soc Nephrol 14 2003 2084 2091 (Pubitemid 36909916)
4. M. Tonelli, L. Moyé, F.M. Sacks, T. Cole, G.C. Curhan Cholesterol and Recurrent Events Trial Investigators Effect of pravastatin on loss of renal function in people with moderate chronic renal insufficiency and cardiovascular disease J Am Soc Nephrol 14 2003 1605 1613 (Pubitemid 36687063)
5. P. Ruggenenti, A. Perna, M. Tonelli, G. Loriga, N. Motterlini, N. Rubis, F. Ledda, S. Rota Jr, A. Satta, A. Granata, G. Battaglia, F. Cambareri, S. David, F. Gaspari, N. Stucchi, S. Carminati, B. Ene-Iordache, P. Cravedi, G. Remuzzi ESPLANADE Study Group Effects of add-on fluvastatin therapy in patients with chronic proteinuric nephropathy on dual renin-angiotensin system blockade: the ESPLANADE trial Clin J Am Soc Nephrol 5 2010 1928 1938
6. T. Aprahamian, R. Bonegio, J. Rizzo, H. Perlman, D.J. Lefer, I.R. Rifkin, and K. Walsh Simvastatin treatment ameliorates autoimmune disease associated with accelerated atherosclerosis in a murine lupus model J Immunol 177 2006 3028 3034 (Pubitemid 44277819)
7. M. Tonelli Do statins protect the kidney as well as the heart? Nephrol Dial Transplant 21 2006 3005 3006 (Pubitemid 44567066)
8. T. Saito Abnormal lipid metabolism and renal disorders Tohoku J Exp Med 181 1997 321 337 (Pubitemid 127471183)
9. J. Jawie, P. Nastaek, and R. Korbut Mouse models of experimental atherosclerosis J Physiol Pharmacol 55 2004 503 517 (Pubitemid 39318844)
10. A.C. Doran, A.B. Lehtinen, N. Meller, M.J. Lipinski, R.P. Slayton, S.N. Oldham, M.D. Skaflen, J. Yeboah, S.S. Rich, D.W. Bowden, and C.A. McNamara Id3 is a novel atheroprotective factor containing a functionally significant single-nucleotide polymorphism associated with intima-media thickness in humans Circ Res 106 2010 1303 1311
11. S. Forrest, and C. McNamara Id family of transcription factors and vascular lesion formation Arterioscler Thromb Vasc Biol 24 2004 2014 2020 (Pubitemid 39482423)
12. I. Ueda-Hayakawa, J. Mahlios, and Y. Zhuang Id3 restricts the developmental potential of gamma delta lineage during thymopoiesis J Immunol 182 2009 5306 5316
13. H. Li, M. Dai, and Y. Zhuang A T cell intrinsic role of Id3 in a mouse model for primary Sjogren's syndrome Immunity 21 2004 551 560 (Pubitemid 39370510)
14. J. Li, T. Maruyama, P. Zhang, J.E. Konkel, V. Hoffman, B. Zamarron, and W. Chen Mutation of inhibitory helix-loop-helix protein Id3 causes γδ T-cell lymphoma in mice Blood 116 2010 5615 5621
15. H. Bagavant, U.S. Deshmukh, H. Wang, T. Ly, and S.M. Fu Role for nephritogenic T cells in lupus glomerulonephritis: progression to renal failure is accompanied by T cell activation and expansion in regional lymph nodes J Immunol 177 2006 8258 8265 (Pubitemid 44846348)
16. S.T. Waters, M. McDuffie, H. Bagavant, U.S. Deshmukh, F. Gaskin, C. Jiang, K.S. Tung, and S.M. Fu Breaking tolerance to double stranded DNA, nucleosome, and other nuclear antigens is not required for the pathogenesis of lupus glomerulonephritis J Exp Med 199 2004 255 264 (Pubitemid 38129705)
17. U.S. Deshmukh, S.R. Nandula, P.R. Thimmalapura, Y.M. Scindia, and H. Bagavant Activation of innate immune responses through Toll-like receptor 3 causes a rapid loss of salivary gland function J Oral Pathol Med 38 2009 42 47
18. U.S. Deshmukh, H. Bagavant, D. Sim, V. Pidiyar, and S.M. Fu A SmD peptide induces better antibody responses to other proteins within the small nuclear ribonucleoprotein complex than to SmD protein via intermolecular epitope spreading J Immunol 178 2007 2565 2571 (Pubitemid 46233459)
19. G.R. Kinsey, R. Sharma, L. Huang, L. Li, A.L. Vergis, H. Ye, S.T. Ju, and M.D. Okusa Regulatory T cells suppress innate immunity in kidney ischemia-reperfusion injury J Am Soc Nephrol 8 2009 1744 1753
20. M. Wen, S. Segerer, M. Dantas, P.A. Brown, K.L. Hudkins, T. Goodpaster, E. Kirk, R.C. LeBoeuf, and C.E. Alpers Renal injury in apolipoprotein E-deficient mice Lab Invest 82 2002 999 1006
21. M.P. Ramprasad, V. Terpstra, N. Kondratenko, O. Quehenberger, and D. Steinberg Cell surface expression of mouse macrosialin and human CD68 and their role as macrophage receptors for oxidized low density lipoprotein Proc Natl Acad Sci U S A 93 1996 14833 14838 (Pubitemid 26419055)
22. L. Li, L. Huang, S.S. Sung, A.L. Vergis, D.L. Rosin, C.E. Rose Jr, P.I. Lobo, and M.D. Okusa The chemokine receptors CCR2 and CX3CR1 mediate monocyte/macrophage trafficking in kidney ischemia-reperfusion injury Kidney Int 74 2008 1526 1537
23. F.K. Swirski, P. Libby, E. Aikawa, P. Alcaide, F.W. Luscinskas, R. Weissleder, and M.J. Pittet Ly-6Chi monocytes dominate hypercholesterolemia- associated monocytosis and give rise to macrophages in atheromata J Clin Invest 117 2007 195 205 (Pubitemid 46048466)
24. S. Gordon Macrophage heterogeneity and tissue lipids J Clin Invest 117 2007 89 93 (Pubitemid 46048455)
25. -/- double knockout mice: a murine model for atherosclerosis and glomerulonephritis. Presented at the American Society of Nephrology Meeting, 2009, October 29November 1, San Diego, CA. Abstract PO1939.
26. -/- C57BL/6 mice: a novel murine model simultaneously exhibits lupus nephritis, atherosclerosis, and osteopenia J Lipid Res 48 2007 794 805 (Pubitemid 46557884)
27. G. Chen, L. Paka, Y. Kako, P. Singhal, W. Duan, and S. Pillarisetti A protective role for kidney apolipoprotein E: regulation of mesangial cell proliferation and matrix expansion J Biol Chem 276 2001 49142 49147
28. E. Liberopoulos, K. Siamopoulos, and M. Elisaf Apolipoprotein E and renal disease Am J Kidney Dis 43 2004 223 233 (Pubitemid 38146320)
29. S.T. Forrest, K.G. Barringhaus, D. Perlegas, M.L. Hammarskjold, and C.A. McNamara Intron retention generates a novel Id3 isoform that inhibits vascular lesion formation J Biol Chem 279 2004 32897 32903 (Pubitemid 39014749)
30. C.J. Sherr, and J.M. Roberts CDK inhibitors: positive and negative regulators of G1-phase progression Genes Dev 13 1999 1501 1512 (Pubitemid 29297917)
31. R.R. Rivera, C.P. Johns, J. Quan, R.S. Johnson, and C. Murre Thymocyte selection is regulated by the helix-loop-helix inhibitor protein, Id3 Immunity 12 2000 17 26 (Pubitemid 30069211)
32. D.H. Atchley, M.F. Lopes-Virella, D. Zheng, D. Kenny, and G. Virella Oxidized LDL-anti-oxidized LDL immune complexes and diabetic nephropathy Diabetologia 45 2002 1562 1571 (Pubitemid 35352050)
33. G. Virella, R.E. Carter, A. Saad, E.G. Crosswell, and B.A. Game DCCT/EDIC Study Group M.F. Lopes-Virella Distribution of IgM and IgG antibodies to oxidized LDL in immune complexes isolated from patients with type 1 diabetes and its relationship with nephropathy Clin Immunol 127 2008 394 400 (Pubitemid 351836069)